Core Insights - Irenic Capital Management LP disclosed a new position in Integer Holdings, acquiring 1,263,663 shares valued at approximately $99.11 million [1][2] Company Overview - Integer Holdings is a leading contract manufacturer in the medical device industry, providing a diverse portfolio of products and technologies to global OEMs [6] - The company specializes in manufacturing medical devices and components for various applications, including cardiology, neuromodulation, orthopedics, vascular, and advanced surgical markets [8] Financial Performance - As of February 17, 2026, Integer Holdings had a market capitalization of $3.07 billion, with a revenue of $1.83 billion and a net income of $86.90 million for the trailing twelve months [4] - The company reported an 8% sales growth in 2025, reaching $1.85 billion, and a 21% adjusted EPS growth to $6.40 [7] - The fourth quarter adjusted EPS increased by 23% to $1.76 [7] Stock Performance - Shares of Integer Holdings were priced at $87.66, reflecting a 37.9% decline over the past year, underperforming the S&P 500 by 49.75 percentage points [7] Investment Implications - The new position by Irenic Capital Management represents 13.7% of their equity assets, indicating a significant but not dominant allocation [10] - Long-term investors are advised to focus on organic growth in Cardio and Vascular sectors, maintaining debt discipline, and executing against the near-term outlook [11]